HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Josep-Maria Ribera Selected Research

Doxorubicin (Adriamycin)

2/2015Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
11/2013Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.
8/2013Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.
10/2011Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas.
2/2008Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Josep-Maria Ribera Research Topics

Disease

32Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2024 - 06/2006
19Philadelphia Chromosome
01/2023 - 01/2010
19Lymphoma (Lymphomas)
12/2021 - 03/2003
17Leukemia
03/2024 - 04/2003
17Neoplasms (Cancer)
06/2023 - 07/2007
9Residual Neoplasm
01/2023 - 01/2014
8Infections
06/2023 - 04/2003
7AIDS-Related Lymphoma (Lymphoma, AIDS Related)
06/2023 - 03/2003
7B-Cell Lymphoma (Lymphoma, B Cell)
08/2021 - 04/2003
6Burkitt Lymphoma (Burkitt's Lymphoma)
08/2023 - 04/2003
6Multiple Myeloma
01/2021 - 04/2007
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2018 - 02/2003
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2015 - 05/2005
5Acquired Immunodeficiency Syndrome (AIDS)
06/2023 - 07/2005
5Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2013 - 10/2005
4Hodgkin Disease (Hodgkin's Disease)
01/2017 - 05/2009
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2016 - 07/2002
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 09/2007
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2021 - 06/2014
3Graft vs Host Disease (Graft-Versus-Host Disease)
10/2021 - 11/2005
3Bites and Stings (Sting)
01/2021 - 01/2015
3Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 11/2007
3HIV Infections (HIV Infection)
04/2015 - 04/2003
3Thrombotic Thrombocytopenic Purpura
06/2011 - 11/2005
2COVID-19
12/2021 - 10/2021
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2021 - 01/2016
2Progressive Multifocal Leukoencephalopathy
11/2019 - 07/2002
2Acute Promyelocytic Leukemia
01/2019 - 01/2019
2Chromosome Aberrations (Chromosome Abnormalities)
10/2011 - 09/2007
2Meningitis
07/2007 - 03/2006
1Hypersensitivity (Allergy)
01/2023
1Communicable Diseases (Infectious Diseases)
12/2021
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2019
1Heart Arrest (Cardiac Arrest)
12/2018
1Hemorrhage
10/2018
1Second Primary Neoplasms (Neoplasms, Second)
01/2018
1Cytokine Release Syndrome
12/2017

Drug/Important Bio-Agent (IBA)

12Rituximab (Mabthera)FDA Link
12/2019 - 09/2002
8blinatumomabIBA
01/2023 - 01/2015
6Imatinib Mesylate (Gleevec)FDA Link
01/2023 - 09/2007
5Doxorubicin (Adriamycin)FDA LinkGeneric
02/2015 - 02/2008
5Vincristine (Oncovin)FDA LinkGeneric
11/2013 - 05/2005
5Prednisone (Sone)FDA LinkGeneric
11/2013 - 05/2005
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013 - 05/2005
4Cytarabine (Cytosar-U)FDA LinkGeneric
10/2008 - 07/2004
3DNA (Deoxyribonucleic Acid)IBA
03/2024 - 10/2011
3Asparaginase (Elspar)FDA Link
01/2023 - 02/2007
3Tyrosine Kinase InhibitorsIBA
01/2022 - 08/2013
3Monoclonal AntibodiesIBA
08/2021 - 01/2015
3Etoposide (VP 16)FDA LinkGeneric
11/2013 - 02/2003
3Methotrexate (Mexate)FDA LinkGeneric
10/2008 - 11/2005
2Phosphotransferases (Kinase)IBA
03/2024 - 01/2022
2ponatinibIBA
01/2023 - 01/2022
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
2AnthracyclinesIBA
01/2019 - 07/2004
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
12/2018 - 02/2003
2Proteins (Proteins, Gene)FDA Link
07/2015 - 10/2011
2Dacarbazine (DIC)FDA LinkGeneric
02/2015 - 08/2013
2Vinblastine (Vinblastine Sulfate)FDA Link
02/2015 - 08/2013
2Bleomycin (Blenoxane)FDA LinkGeneric
02/2015 - 08/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2012 - 02/2008
2Protons (Proton)IBA
11/2009 - 04/2007
1Busulfan (Busulfex)FDA Link
05/2024
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
05/2024
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
10/2021
1Oxygen (Dioxygen)IBA
10/2021
1pembrolizumabIBA
08/2021
1LigandsIBA
08/2021
1idecabtagene vicleucelIBA
01/2021
1Proteasome InhibitorsIBA
01/2021
1AntibodiesIBA
01/2021
1Immunomodulating AgentsIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2020
1GemcitabineFDA Link
12/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2019
1Mirtazapine (Rexer)FDA LinkGeneric
11/2019
1Mefloquine (Lariam)FDA LinkGeneric
11/2019
1Lenalidomide (CC 5013)FDA Link
01/2019
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2019
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2019
1Fibrinolytic Agents (Antithrombotic Agents)IBA
10/2018
1Vascular Endothelial Growth Factor CIBA
10/2018
1pegaspargase (Oncaspar)FDA Link
01/2018
1PerforinIBA
01/2015
1Melphalan (Alkeran)FDA LinkGeneric
12/2014

Therapy/Procedure

29Drug Therapy (Chemotherapy)
06/2023 - 04/2003
27Therapeutics
06/2023 - 04/2003
14Stem Cell Transplantation
05/2024 - 07/2004
10Highly Active Antiretroviral Therapy (HAART)
04/2015 - 03/2003
7Hematopoietic Stem Cell Transplantation
01/2021 - 07/2004
6Transplantation
12/2021 - 06/2006
5Immunotherapy
01/2020 - 07/2008
3Salvage Therapy
10/2021 - 01/2015
3Radiotherapy
08/2015 - 08/2009
2Consolidation Chemotherapy
01/2022 - 02/2003
2Aftercare (After-Treatment)
04/2007 - 10/2005
1Drug Tapering
08/2023
1Homologous Transplantation
01/2021
1Complementary Therapies (Alternative Medicine)
01/2019
1Cryotherapy (Therapy, Cold)
12/2014